CP and neoplasm: Previous research found that immunophenoscore (IPS) can be used to evaluate tumor immunogenicity and predict the response to immune checkpoint inhibitor, which was classified into four categories, including MHC molecules (MHC), immunomodulators (CP), effector cells (EC) and suppressor cells (SC) (Charoentong et al., 2017).